Dr. Kwatra’s Insights on Emerging Advances in Chronic Itch
As dermatologists, we recognize that chronic itch is a complex and often debilitating condition that significantly impacts our patients' quality of life, affecting their physical health, mental well-being, and daily activities. Chronic itch can be especially challenging to diagnose and treat, particularly in patients with skin of color, who may experience unique clinical manifestations and complic …
As dermatologists, we recognize that chronic itch is a complex and often debilitating condition that significantly impacts our patients' quality of life, affecting their physical health, mental well-being, and daily activities. Chronic itch can be especially challenging to diagnose and treat, particularly in patients with skin of color, who may experience unique clinical manifestations and complic … Continue reading "Dr. Kwatra’s Insights on Emerging Advances in Chronic Itch"
The many alternatives to hydroquinone make this an exciting time for using cosmeceuticals to treat pigmentary disorders, according to Dr. Heather Woolery-Lloyd, director of the Skin of Color Division at the University of Miami Miller School of Medicine’s Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery. In an interview with Next Steps in Derm, in partnership with Pigmentary Diso … 
INTRODUCTION
Melanoma accounts for only 1% of all skin cancers but is responsible for most skin cancer-related deaths.1 Acral and mucosal melanoma (AMM) accounts for only 4% of all new melanomas but is associated with poorer prognosis.2 Patients of color are disproportionately affected by AMM. Elucidating the clinical, genetic, and environmental features of AMM can guide advancements in the … 
Dr. Valerie M. Harvey’s insightful presentation at the 2024 Skin of Color Update focused on the unique clinical and pathological features of basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma in patients with skin of color. As the founder and clinical director of the Hampton Roads Center for Dermatology and a past president of the Skin of Color Society, Dr. Harvey brought he … 
Understanding the pathogenesis of vitiligo can help determine new treatment targets. Dr. John Harris, professor and chair of the dermatology department at UMass Chan Medical School, shared the latest advances in understanding what causes vitiligo in an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium. Watch as Dr. Harris explains the role of the immune … 